ALMAC

Highly Engaged Employees

ALMAC, established in 2002, operates as a leading contract development and manufacturing organization (CDMO) for the pharmaceutical and biotech industries. Headquartered in the United Kingdom, the company provides a comprehensive suite of integrated services supporting the entire drug lifecycle, from discovery and development to manufacturing. Its core focus areas cater to a global clientele seeking specialized expertise in advancing novel therapeutics and diagnostics. ALMAC's commitment to innovation and quality positions it as a key partner for companies in the Pharmaceuticals and Healthcare sectors.

With 5,000 - 10,000 employees distributed across 39 global locations, ALMAC demonstrates significant operational scale and reach. The company offers pharmaceutical development, clinical trial support, and companion diagnostic test creation, enabling clients to navigate complex pathways efficiently. For insights into the leadership driving these operations, one can Meet ALMAC's team. Their integrated approach ensures seamless project progression from early-stage research through to commercialization, underscoring their role as a vital service provider in the healthcare ecosystem.

ALMAC generates substantial revenue, reported at $1.3B, reflecting its significant market presence. It competes with major industry players like Pfizer, Bristol-Myers Squibb, Regeneron, Illumina, and Bio-Rad, among others. Its strategic focus on integrated, end-to-end solutions differentiates it in a competitive landscape. By offering expertise across drug discovery, development, manufacturing, and diagnostics, ALMAC supports the advancement of critical medicines and healthcare technologies worldwide, facilitating the complex journey of bringing new treatments to patients.